Biotech Startup Mirxes Weighs $300 Million Singapore IPO

Bloomberg2022-06-27

Mirxes Pte, a Singapore-based biotechnology startup, is weighing an initial public offering in the city-state next year that could raise about $300 million, according to people with knowledge of the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Noobplayer
2022-06-28
Noobplayer
Great....
- Noobplayer:
  Great
Brian2105
2022-06-27
Brian2105
Ok
Tenten
2022-06-27
Tenten
Wow
SaveHK
2022-06-27
SaveHK
Nice👏👏👏
StarGalaxy
2022-06-27
StarGalaxy
Ok
Pluto891
2022-06-27
Pluto891
now here

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146571440?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-06-27 17:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146571440","market":"sg","top_or_hot":-1,"title":"Biotech Startup Mirxes Weighs $300 Million Singapore IPO","media":"Bloomberg","content":"<div>\n<p>Mirxes Pte, a Singapore-based biotechnology startup, is weighing an initial public offering in the city-state next year that could raise about $300 million, according to people with knowledge of the ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-06-27/biotech-startup-mirxes-said-to-weigh-300-million-singapore-ipo\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biotech Startup Mirxes Weighs $300 Million Singapore IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiotech Startup Mirxes Weighs $300 Million Singapore IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-27 17:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-06-27/biotech-startup-mirxes-said-to-weigh-300-million-singapore-ipo><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mirxes Pte, a Singapore-based biotechnology startup, is weighing an initial public offering in the city-state next year that could raise about $300 million, according to people with knowledge of the ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-06-27/biotech-startup-mirxes-said-to-weigh-300-million-singapore-ipo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STI.SI","symbol_name":"富时新加坡海峡指数","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2022-06-27/biotech-startup-mirxes-said-to-weigh-300-million-singapore-ipo","article_id":"1146571440","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146571440","pubTimestamp":1656323409,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Mirxes Pte, a Singapore-based biotechnology startup, is weighing an initial public offering in the c","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"translate_title":"生物技术初创公司Mirxes在新加坡上市3亿美元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STI.SI":0.9},"content_text":"Mirxes Pte, a Singapore-based biotechnology startup, is weighing an initial public offering in the city-state next year that could raise about $300 million, according to people with knowledge of the matter.The company is in discussions with bankers about a potential offering that could value it at over $1 billion, said the people, who asked not to be identified as the process is private.Deliberations are ongoing and Mirxes could decide not to proceed with the offering, said the people. Calls and emails to Mirxes seeking comment were not returned.Any listing would help to further stimulate the IPO market in Singapore. First-time share sales in the city-state totaled $348 million so far this year, up from $242 million in the same period last year, according to data compiled by Bloomberg.Founded in 2014 as a spinoff from Singapore’s Agency for Science, Technology and Research, also known as A*STAR, Mirxes focuses on early detection of multiple cancers using proprietary RNA-powered blood tests, according to its website. The startup raised $87 million in a series C funding round in 2021, taking the total amount raised to $130 million since its inception.Mirxes has operations in China, Japan and the US and commercial activities in over 45 countries, according to a recent press release. In 2020 the startup along with A*STAR and others worked to mass produce Singapore’s first authorized Covid-19 PCR test, with more than 8 million kits deployed globally.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":683263982,"gmtCreate":1656372164950,"gmtModify":1676533272609,"author":{"id":"4099647582870040","authorId":"4099647582870040","name":"Noobplayer","avatar":"https://community-static.tradeup.com/news/27f6557de29ea58036b5b45b03c61d17","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"4099647582870040","idStr":"4099647582870040"},"htmlText":"Great....","listText":"Great....","text":"Great....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/683263982","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7505908,"gmtCreate":1656372220027,"gmtModify":1663241078466,"authorId":4099647582870040,"author":{"id":4099647582870040,"idStr":"4099647582870040","authorId":4099647582870040,"name":"Noobplayer","avatar":"https://community-static.tradeup.com/news/27f6557de29ea58036b5b45b03c61d17","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":683263982,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"CN"},{"id":9046874888,"gmtCreate":1656336328644,"gmtModify":1676535808151,"author":{"id":"4090066386792810","authorId":"4090066386792810","name":"Brian2105","avatar":"https://static.tigerbbs.com/ef183682b7bc3985f934b772dfadf99b","vip":1,"crmLevel":1,"crmLevelSwitch":1,"authorIdStr":"4090066386792810","idStr":"4090066386792810"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046874888","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9046815057,"gmtCreate":1656327491279,"gmtModify":1676535806607,"author":{"id":"3586686286785362","authorId":"3586686286785362","name":"Tenten","avatar":"https://static.tigerbbs.com/6aaa492013925eb5bfe2cb43461ebfe4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3586686286785362","idStr":"3586686286785362"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046815057","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9046816401,"gmtCreate":1656327244303,"gmtModify":1676535806567,"author":{"id":"3570678493691973","authorId":"3570678493691973","name":"SaveHK","avatar":"https://static.tigerbbs.com/89b74f5799a23844400ed6de94296d38","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3570678493691973","idStr":"3570678493691973"},"htmlText":"Nice👏👏👏","listText":"Nice👏👏👏","text":"Nice👏👏👏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046816401","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9046811146,"gmtCreate":1656326964485,"gmtModify":1676535806512,"author":{"id":"4090381790893340","authorId":"4090381790893340","name":"StarGalaxy","avatar":"https://static.tigerbbs.com/49916fa198da24e2605abf24a28d23d2","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4090381790893340","idStr":"4090381790893340"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046811146","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9046896051,"gmtCreate":1656324233673,"gmtModify":1676535805995,"author":{"id":"3581937910767045","authorId":"3581937910767045","name":"Pluto891","avatar":"https://static.tigerbbs.com/c9963f2ef3d3ad2aff28340461d3d6d0","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3581937910767045","idStr":"3581937910767045"},"htmlText":"now here","listText":"now here","text":"now here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9046896051","repostId":1146571440,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":58,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146571440"}